Concepedia

Laure Siraudin

LS

3

Publications

408

Citations

3

H-Index

2001

Active since

Affiliations

University Hospital Brno(Current)

Charles University

The Ohio State University

Ospedale Vincenzo Cervello

Ospedale Papa Giovanni XXIII

Laure Siraudin is an author at University Hospital Brno specializing in cancer research, medicine, and tumor immunity.

Top concepts

MedicineOncologyPathologyImmunologyImmunotherapyTumor ImmunityCancer ResearchMolecular OncologyImmune Surveillance

Publications per year

2001–2018

3

Publications

3

Costs of asthma are correlated with severity: a 1-yr prospective study

Philippe Godard, Pascal Chanez, Laure Siraudin et al. · European Respiratory Journal · 2001 · 332 citations · Full text

A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

Marek Trněný, Gregor Verhoef, Martin J.S. Dyer et al. · Haematologica · 2018 · 60 citations · Full text

Starlyte phase II study of coltuximab ravtansine (CoR, SAR3419) single agent: Clinical activity and safety in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL; NCT01472887).

Marek Trněný, Gregor Verhoef, Martin J.S. Dyer et al. · Journal of Clinical Oncology · 2014 · 16 citations

R/r Dlbcl, Immunology, Pathology +16

Rows per page

1–3 of 3